Impilo's prototype platform scours medical records to pinpoint symptoms of unusual illnesses that are often overlooked by ...
Our goals are to expand access to genomic testing and develop cutting-edge genomic testing to help more families get answers ...
PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...
Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...